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Introduction
!
Probe-based confocal laser endomicroscopy
(pCLE) and its related technology, endoscope-
based CLE (eCLE), are rapidly emerging methods
of imaging with the potential to fundamentally
change the role of biopsy in gastrointestinal en-
doscopy. Since the advent of endoscopic imaging,
biopsy has been used to confirm or exclude pa-
thology. Although highly valuable, biopsy is ex-
pensive, and there can be delays between endos-
copy and a “confirmed” diagnosis and/or treat-
ment. In addition, although the risks associated
with biopsyaresmall, the number of biopsiesper-
formed worldwide is enormous, and therefore
risk becomes an important consideration.
CLE methods offer the potential to decrease or
possibly eliminate the need for some biopsies
and to directly guide treatment of circumscribed
lesions, such as colorectal polyps, in real time.
CLE can also help to avoid biopsy, or if biopsy is
necessary, to direct it much more efficiently in
areas of very low diagnostic yield, such as in sur-
veillance of Barrett’s esophagus, ulcerative colitis,
and indeterminate bile duct strictures. Although
it is still premature to determine the exact roles
of pCLE in each gastrointestinal condition, it is es-
sential to establish standards for image interpre-
tation at an early stage of development.
We determined that a unique classification sys-
tem was needed for pCLE due to the significant
technical differences compared with eCLE (smal-
ler field of view, fixed depth), as well as the fact
that many of the eCLE images published in the lit-
eraturehave used acriflavine (a nuclear stain) and
are not comparable to pCLE images, which are al-
most exclusively obtained with fluorescein-only
contrast.
Methods for development of criteria
!
A group of experts was assembled based on their
earlyexperience with pCLE imaging in avariety of
gastrointestinal conditions. As pCLE technology is
new, there was a limited number of individuals
with significant expertise in each field prior to
February 2009, and a limited number of clinical
trials on which to establish standards. Thus the
standards were largely based on expert opinion,
and consensus development. In general, each
group developed criteria based on the following
algorithm:
▶ acquisition and review of unended images
with pathological confirmation
▶ description of features unique to each histolo-
gical state (e.g. metaplasia, neoplasia)
▶ pilot testing of accuracy in a small sample of
cases blinded to the histology
▶ where available validation, including inter-ob-
server agreement, in a large sample with mul-
tiple users.
The Miami consensus conference involved pre-
sentation of standard images and specific features
of each condition, together with group discussion
and consensus development. Following the con-
ference, a report was drafted by the lead co-au-
thor for each section, and the final criteria and
manuscript were approved by all co-authors.
Wallace M et al. Miami classification for pCLE… Endoscopy 2011; 43: 882–891
An essential element for any new advanced ima-
ging technology is standardization of indications,
terminology, categorization of images, and re-
search priorities. In this review, we propose a
state-of-the-art classification system for normal
and pathological states in gastrointestinal disease
using probe-based confocal laser endomicroscopy
(pCLE). The Miami classification system is based
on a consensus of pCLE users reached during a
meeting held in Miami, Florida, in February 2009.
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.General techniques for pCLE
!
Probe technology
The confocal microscope used in pCLE captures microscopic ima-
ges of untreated in vivo tissue. The microscope uses focused laser
light of a defined wavelength and passes it through a confocal
aperture. Images are then reconstructed in two dimensions.
For pCLE (Cellvizio by Mauna Kea Technologies, Paris, France),
both the laser scanning unit and light source are outside the
body. The laser beam is transported via flexible confocal minip-
robes and a distal lens sequentially scans it through a bundle of
more than 10000 optical fibers. Confocal miniprobes are flexible,
with diameters ranging from 0.9 mm to 2.5 mm. Therefore, this
system may be introduced through the working channels of en-
doscopes (● " Fig.1).
Image acquisition, processing, and display
pCLE image data are collected at 12 frames per second, enabling
video quality and direct visualization of blood on a single ery-
throcyte scale. Depending on the probe used, the field of view
ranges from 240 μm to 600 μm (one-quarter to one-half of a mil-
limeter). The clinical system consists of a miniprobe connected to
a laser scanning unit that is connected to a standard personal
computer for image data processing and display (● " Fig.1). Ima-
ges are reviewed with a specially designed software package
(Cellvizio Viewer), allowing image correction and stabilization.
Contrast agents, dose, and safety
Different dyes,suchasfluorescein orcresylviolet, havebeen used
for contrast enhancement [1–3]. Cresyl violet may only be admi-
nistered topically, whereas fluorescein may also be injected in-
travenously. Fluorescein is the current substance of choice be-
cause it is relatively inexpensive, non-mutagenic, enables higher
imaging depth than topicallyadministered contrast agents, and it
has been safely used for decades in ophthalmology [4]. Injection
of 1.0–5.0 mL ofa 10% solution enables visualization of individual
cells with strongcontrastof the capillary network. This is the cur-
rent standard dosage in most settings. Hence, dynamic images of
blood flow and supply are possible, making it a useful tool for de-
tection of neo-angiogenesis [5].
The exact mechanism by which neoplastic cells appear dark is
poorly understood. It is clear that fluorescence is not seen within
these cells. Several mechanisms have been proposed including
lack of fluorescein uptake, more rapid excretion from the cell
[1], or greater leakage into the lamina propria, thus increasing
the relative darkness of the epithelial cells [6].
Endoscopic techniques for high-quality image
acquisition of mucosal disease
The keys to obtaining high quality images are timing, positioning,
and stability. Gradual changes in image quality occur in a time-
dependant fashion after intravenous injection of fluorescein. Op-
timal contrast is obtained within the first 10min after injection,
but good quality images can be acquired for a further 30–60 min
[3]. However, bleeding can impair image quality; therefore, the
probe should be placed gently in contact with the tissue in order
to avoid trauma, particularly if friability is expected, such as in
neoplasms or severely inflamed tissue. As with other imaging
methods, it is best to complete pCLE imaging in a region before
biopsy or tissue removal is completed.
If possible, the probe should be perpendicular to the mucosa,
rather than parallel to it. This can be difficult if the lumen is very
Fig.1 The probe-based confocal laser endo-
microscopy (pCLE) system. a Probe within standard
endoscope. b Laser scanning unit and display.
c Fiber probe. d Fiber probe with blue laser
illuminated.
Wallace M et al. Miami classification for pCLE… Endoscopy 2011; 43: 882–891
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.narrow, as in biliary strictures. In these circumstances, a cholan-
gioscopical approach or biliary catheter with side hole or bend-
able tip might help to maneuver the probe into the wall of the
bile duct.
Movements caused by the examiner or the patient (breathing or
peristalsis) can significantly impair positioning of the probe and
cause artifacts. Using a clear 4-mm cap on the tip of the endo-
scope and applying gentle suction helps to hold the probe in po-
sition. This approach can be very helpful for the imaging of Bar-
rett’s esophagus or small colonic polyps.
Other methodstoimprovethe matchbetweenpCLE imagingsites
and biopsy sites include the use of a dual-channel endoscope
(with pCLE probe in one channel and biopsy forceps in the other)
or the use of cautery marking with argon plasma coagulation or
coagulating (“hot”) biopsy forceps. The most useful methods for
research studies require highly precise matching of image and
biopsy locations.
Applications of pCLE
The main focus of pCLE has been the detection and classification
of neoplasia in Barrett’s esophagus and colonic polyps. However,
several other conditions have also been studied to a lesser extent
and others are just beginning to be studied.● " Table1 lists these
potential applications in order of the current extent of evidence.
Comparison of eCLE and pCLE
Both endoscopy- and probe-based methods of CLE have advanta-
ges and disadvantages. eCLE offers a wider field of view, the abil-
ity tovary the depth of imaging from 0–250 μm compared with a
fixed imaging plane (approximately 50 μm below the surface of
GastroFlex), and slightly better lateral resolution (approximately
0.8 μmvs. 1 μm). Advantages of pCLE are the versatilityof a probe
system that can be passed via any endoscope, or even needles,
and more rapid image acquisition (12 frames per second vs. 0.8–
1.6 frames/s), which allows imaging of in vivo blood flow. Both
systems have inherent limitations compared with wide field en-
doscopic methods, including the very small field of view, cost of
the technology, learning curve, and extra time needed to view
the images during endoscopy.
Barrett’s esophagus
!
Surveillance guidelines for the management of patients with Bar-
rett’s esophagus call for target biopsies from visible lesions, fol-
lowed by random four-quadrant biopsies every 2 cm [7]. This
practice is time-consuming, costly, and challenging as sampling
is not always accurate. Detailed analysis of esophagectomy speci-
mens from patients with Barrett’s esophagus has revealed that
areas of low-grade dysplasia (LGD), high-grade dysplasia (HGD),
and cancer are extremely focal and occupy extremely small areas
within the Barrett’s segment [8]. To overcome these shortcom-
ings, advanced endoscopic techniques including pCLE have been
developed to maximize the positive and negative predictive val-
ues of dysplasia detection in patients with Barrett’s esophagus.
CLE is a highly targeted technology that may be useful for lesion
classification. However, other technologies, such as narrow band
imaging (NBI), autofluorescence imaging (AFI), and chromoen-
doscopy are needed as “broad-base surface imaging” techniques
to initially detect and localize suspicious areas.
Inpatients with Barrett’s esophagus, CLE captures very high reso-
lution and detailed images including glandular architecture,
crypts, columnar cells, goblet cells, and capillaries with red blood
cells. In patients with a columnar-lined esophagus, the diagnosis
of Barrett’s esophagus can be confirmed by identifying and con-
firming the presence of intestinal metaplasia, which is character-
ized by the presence of goblet cells. Furthermore, based on preli-
minary data, CLE also has high accuracy in detecting HGD or can-
cer.
Classification of CLE images as non-dysplastic or dysplastic has
been evaluated in a few pilot studies using varying criteria [3,4].
An initial study by Kiesslich et al. evaluated criteria for gastric
type, intestinal and neoplastic epithelium, based on cellular and
vascular architecture details of CLE images [9]. Images that de-
monstrate regular-shaped capillaries visible only in deeper mu-
cosa, regular columnar-lined epithelium with round glandular
openings, and typical cobblestone appearance, were suggestive
of gastric-type foveolar epithelium; whereas, regular capillaries
that were present in upper and deeper parts of the mucosal layer
along with identification of dark (“non-refractile”) mucin in gob-
let cells in columnar-lined mucosa, were diagnosed as intestinal
metaplasia (non-dysplastic Barrett’s esophagus). The diagnosis
of dysplasia/cancer was based on the identification of irregular
capillaries in upper and deeper parts of the mucosal layer (sug-
gestive of neo-angiogenesis) with black cells that had irregular
apical and distal borders and shapes on confocal images. Using
these criteria, Barretts-associated dysplasia could be predicted
with a sensitivity of 93% and a specificity of 98%. Compared with
gastric metaplasia, Barrett’s metaplasia could be predictedwith a
sensitivity of 98% and a specificity of 94%.
In another recent study, Pohl et al. tested the diagnostic charac-
teristics of pCLE for the detection of invisible Barrett’s-associated
dysplasia [10]. The investigators initiallyestablished pCLE criteria
for neoplastic Barrett’s esophagus including dark, irregularly
thickened epithelial borders, dilated irregular vessels, and in ade-
nocarcinoma, disorganization of villiform structures and crypts
and dark columnar cells. These criteria were established from 95
biopsies (15 patients) and then tested prospectively in 201 biop-
sies (23 patients). pCLE videos were also assessed by two endos-
copists and the inter-observer agreement was tested. The overall
sensitivity, specificity, positive predictive value (PPV) and nega-
tive predictive value (NPV) were 80%, 94%, 44%, and 99%, respec-
tively, with good inter-observer agreement (Kappa=0.6). A wide
group of expert endoscopists evaluated these criteria and valida-
ted them as reliable and reproducible.
Using a standardized setof 20 video images ofdysplastic [11] and
non-dysplastic Barrett’s sites [10], Wallace et al. reported preli-
minary sensitivity of 88% and specificity of 96% and good inter-
observer agreement (agreement rate 86%, Kappa=0.72) [12].
These pCLE criteria have now been tested andvalidated in a large,
prospective, multi-center, randomized controlled trial (DON’T
Table1 Potentialapplicationsof(probe-based)confocal laserendomicro-
scopy.
Well-evaluatedareas
Barrett’sesophagusguidetobiopsy
Colon polypclassification
Areasofearlyexploration
Inflammatory boweldisease dysplasia
Biliary strictures
Duodenal neoplasia
Experimentalareas
Solidandcystic tumorimaging
Gastric neoplasia
Wallace M et al. Miami classification for pCLE… Endoscopy 2011; 43: 882–891
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.BIOPCE trial) [13]. This trial used independent, blinded endosco-
pists to perform tandem endoscopic procedures to evaluate the
sensitivity and specificity of pCLE in addition to white light en-
doscopy for the detection of HGD and early adenocarcinoma in
Barrett’s esophagus. Final data presented at Digestive Disease
Week 2010 (1–6 May, New Orleans, Louisiana, USA) included
874 sites (120 with high grade intra-epithelial neoplasia [HGIEN]
orcancer)in 101 patients (31 with HGIENorcancer). On a per pa-
tient basis, the combination of pCLE with high-definition white
light endoscopy was significantly more accurate than endoscopy
alone (sensitivity/specificityof pCLE + endoscopy 95%/67% vs. en-
doscopy 85%/71%). The addition of pCLE to endoscopy and NBI
was also more accurate than endoscopy + NBI alone (sensitivity/
specificity of pCLE + endoscopy + NBI 100%/56% vs. endoscopy +
NBI 97%/56%). Using pCLE to guide biopsy in patients with Bar-
rett’s esophagus, where only suspicious sites are biopsied would
result in a 76% reduction in biopsies with no HGIEN patients mis-
sed, although 24% of sites would have been missed. If pCLE was
Fig.2 Esophagus. a Graphic of Barrett’s mucosa
with villiform non-dysplastic epithelium (left side)
progressing to higher grades of dysplasia and can-
cer (right). The estimated image “slice” of probe-
based confocal laser endomicroscopy (pCLE) is
shown in blue. b pCLE images and histology of
esophageal conditions including Barrett’s esopha-
gus. In normal squamous epithelium, two pCLE
images are shown as well as standard histology with
hematoxylin and eosin (H&E). For Barrett’s esopha-
gus, high-grade dysplasia, and adenocarcinoma, a
pCLE image is shown on the left and a correspond-
ing H&E image of the same condition is shown on
the right.
Normal squamous epithelium
Non dysplastic Barrett‘s esophagus
– Flat cells without crypts 
 or  villi
– Bright vessels within 
  papillae (intra papillary 
 capillary  loops)
– Uniform villiform 
 architecture
– Columnar cells 
 (block  arrow)
– Dark „goblet“ cells 
 (thin  arrow)
High grade dysplasia
– Villiform structures
– Dark, irregularly 
 thickened  epithelial 
 borders  (arrow)
– Dilated irregular vessels 
 (block  arrow)
Adenocarcinoma
b
– Disorganized/loss of 
  villiform structure and 
 crypts
– Dark columnar cells 
 (thin  arrow)
– Dilated irregular vessels 
 (block  arrow)
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.used to guide biopsy, and four-quadrant random plus targeted
biopsies were taken only in those patients with at least one ab-
normal lesion on pCLE, then this would result in a 39% reduction
in biopsies with no missed sites or patients. In summary, CLE
criteria for dysplastic and non-dysplastic Barrett’s esophagus
havebeen established and tested in pilot studies. Their validation
in a large multicenter study is ongoing and eagerly awaited. It is
likely that these criteriawill continuetobe refined as larger stud-
ies are conducted.
● " Fig.2 shows the current pCLE-based classification system with
image and histological examples.
Biliary disease
!
Accurate diagnosis and staging of pancreatobiliary cancers is im-
portant for both prognosis and for guiding therapy; however, it
remains challenging to differentiate benign from malignant stric-
tures despite advanced imaging and tissue sampling methods. Up
to 15% of all suspected cholangiocarcinomas originating from the
liver hilum reveal benign histology following surgery [11]. Con-
versely, only 20% of hilar cancers are resectable at the time of di-
agnosis,and the rate of R0 resections is unfavorablylow [14]. This
diagnostic dilemma holds true despite the introduction of tissue
sampling methods such as biopsy, brush cytology, or fine-needle
aspiration (FNA) cytology through endoscopic retrograde cholan-
giopancreatography (ERCP) or endoscopic ultrasound (EUS). The
best outcomes are obtained when several sampling techniques
are combined, but even they remain suboptimal. Rösch et al. re-
ported that combining brush cytology with forceps biopsy yiel-
ded a sensitivity of 54% and a specificity of 100% [15]. If endo-
scopic ultrasound-guided fine-needle aspiration (EUS–FNA) was
added to these methods, then the sensitivity increased to 71%,
but specificity was still 100%. Ponchon et al. reported that com-
bining brush cytology and forceps biopsy yielded a sensitivity of
63% and a specificity of 97% [16]. Schoefl et al. showed that the
combination of brush cytology and biopsy yielded a sensitivity
of 70.4% and a specificity of 100% [17]. Hence, there is a critical
need to improve the diagnostic accuracy of pancreatobiliary pa-
thology, thereby enabling a more tailored approach for patients
and minimizing unnecessary operations.
pCLE that provides in vivo microscopic imaging of tissues in real
time can be introduced through the working channel of an ERCP
catheter or cholangioscope, in order to access and visualize the
pancreatobiliary ductal system during the procedure. Meining et
al. reported on a series of 14 patients with biliary strictures that
were examined by pCLE via cholangioscopy, and compared the
modality to standard endoscopic tissue sampling [18]. pCLE ima-
ging of the biliary stricture was feasible in all cases. The presence
of irregular, dilated (“angiogenic”) vessels was the laser micro-
scopic hallmark for prediction of neoplasia, with an accuracy of
86%, sensitivity of 83%, and specificity of 88%. The respective
numbers for standard histopathology were 79%, 50%, and 100%.
The mean signal-to-noise-ratio of endomicroscopic images ac-
quired from malignant strictures differed significantly from
those of benign origin (1.8±0.8 vs. 2.6±1.0; P=0.005). As a preli-
minary conclusion, pCLE could considerably increase sensitivity
for the detection of pancreatobiliary neoplasia, and therefore, re-
presents a promising diagnostic approach. Large multicentric
studies are ongoing.
To date, pCLE examination during ERCP procedures has been se-
lectively applied to patients with signs, symptoms, or test results
that indicate malignancy or indeterminate pancreatobiliary stric-
ture. The technique for pancreatobiliary pCLE is straightforward.
ERCP is performed in accordance with the standard of care, and
the stricture is accessed either with an ERCP catheter or a cholan-
gioscope. The pCLE probe is introduced through the lumen of the
catheter or the working channel of the cholangioscope, and the
lesion of interest is targeted for microscopic imaging using
fluoroscopy or endoscopic guidance. The pCLE probe is posi-
tioned at the site(s) of suspected pathology immediately follow-
ingintravenous injection of fluorescein sodium. Real-time invivo
sequences are acquired and stored for review, usually immedi-
ately after a site of interest has been imaged.
The choice of the optimal access delivery system for pCLE during
ERCP (catheter vs. cholangioscopic access and delivery) is cur-
rently being investigated. In part, the decision depends on the
endoscopy unit resources and operator preference. Initial experi-
ence with pCLE during ERCP procedures shows that real-time se-
quencescan be obtainedwith eitherdelivery method [19]. Avari-
ety of catheter models have been used in conjunction with the
miniprobe (see● " Table2). Access through the SpyGlass system
(Boston Scientific, Natick, Massachusetts, USA), Olympus cholan-
gioscopes (Olympus Corp., Tokyo, Japan), and Storz prototype
cholangioscope (Karl Storz GmbH, Tuttlingen, Germany) are all
also possible.
The Cellvizio CholangioFlex probe is dedicated to pCLE during
ERCP procedures, and it has been miniaturized to an external di-
ameter of 0.94 mm, in order to meet the constraints of intraduc-
tal access devices. The probe fits inside lumens of 1.2 mm in di-
ameter, has a field of view of 325 µm, a lateral resolution of 3.5
µm, and an imaging depth of 40–70 µm below the tissue surface.
Specific pCLE image interpretation criteria are under develop-
ment.● " Fig.3 shows typical pCLE findings in normal bile ducts
and biliary cancer.
Colorectal disease
!
Several advanced imaging techniques may play a role in facilitat-
ing both the detectionof dysplasia in the colon, as well as classifi-
cationbetween neoplastic and non-neoplastic lesions during co-
lonoscopy. CLE can provide imaging of single cells, making it un-
suitable for the detection of lesions in the colon; however, it has
Table2 Listofendoscopic retrograde cholangiopancreatography (ERCP)
devicesthat havebeenusedsuccessfully andcanaccommodatethe Cholan-
gioFlex probe (Cellvizio, Mauna Kea Technologies, Paris). Thelist is based on
clinical experiences ofcurrentusers of probe-based confocal laser endomi-
croscopyanddoesnotrepresentarecommendationfromthemanufacturers.
Differences in sizeand diameter of the working channel mightimpair the
compatibility in some cases.
Device name Manufacturera
Cotton® GraduatedDilationCatheterT7.0 CookMedical
OASIS® One Action Stent Introduction
System
Cook Medical
MemoryDormiabasket (Ref MSB_35_2X4
MemoryII)
Cook Medical
Howell Biliary Introducer (H-BIN) Cook Medical
Geenen® Graduated Dilation Catheter Cook Medical
Swing Tip™ ERCP cannula Olympus Medical
a Cook Medical, Inc., Bloomington, Indiana, USA; Olympus Medical Systems, Tokyo,
Japan
Wallace M et al. Miami classification for pCLE… Endoscopy 2011; 43: 882–891
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.the potential to differentiate dysplasia from non-neoplastic tis-
sue in a targeted approach [2,20,21].
Chromoendoscopy, NBI, and a combination of NBI and AFI called
endoscopic trimodal imaging (ETMI) may predict histology based
on the Kudo pit pattern, vascular pattern intensity (VPI), and col-
or. All of these techniques have a rather low specificity. CLE, how-
ever, has the potential toprovide real-time conventional histopa-
thology with a very high specificity.
Ideally, a method with a high detection rate of neoplastic lesions
(usuallyat the cost of lower specificity) should be combined with
a method of optimal differentiation of all detected lesions. Such
combinations can be made by pan-colonic chromoendoscopy or
autofluorescence as a “red flag technique” used in conjunction
with endoscopic pit pattern analysis and CLE for the differentia-
tion of detected lesions.
Colorectal polyps
!
The detection of neoplastic lesions has been significantly im-
proved by chromoendoscopy compared with conventional colo-
noscopy, whereas NBI only showed an improvement during the
learning phase [22,23]. In one randomized study ETMI (white
light + NBI + AFI) did not result in an increased adenoma detec-
tion rate [24].
Conventional endoscopy has limited ability to discriminate ade-
nomatous from non-adenomatous colorectal polyps. In daily
practice, all identified lesions are routinely removed and sent for
histopathology. This approach results in substantial increase of
endoscopic workload, additional pathology costs, and increase
in potential complications. If CLE could reliably predict histology,
then it could increase cost-effectiveness and efficiency consider-
ably. This is a concept suggested by several prominent colonosco-
pists [25].
However, the decision to decide to leave a polyp in situ and not
send it for pathology requires high accuracy and particularly
high NPV of the imaging method. Chromoendoscopy, NBI, and
AFI have shown unacceptable test characteristics for this pur-
pose, with accuracies of 91%, 89%, and 79%, respectively [24].
CLE has shown high agreement with true histopathology. In ear-
lier feasibility studies, Kiesslich et al. demonstrated an accuracy
of 99% with the integrated system, whereas, feasibility studies
with the probe-based system reached an accuracy of 82–92%
[2,20,21].
A prospective study of CLE in polyp differentiation has been pub-
lished. Sanduleanu et al. performed a prospective study using
chromoendoscopy-guided CLE with the integrated system to
evaluate differential features ofadenomatous and non-adenoma-
tous colorectal polyps, resulting in an accuracy of 96% [26]. Acri-
flavine was used in conjunctionwith fluorescein, enabling discri-
mination of HGD from LGD, with an accuracy of 97%.
Anotherlarge prospective double-blind trial compared pCLEwith
NBI and Fujinon Intelligence Color Enhancement (FICE, Fujinon,
Fort Wayne, New Jersey, USA), for polyp classification. Buchner
et al. demonstrated that pCLE was superior to digital chromoen-
doscopy methods; however, it was primarily superior to FICE
without significant improvement over NBI. The sensitivity of
pCLE for neoplastic polyps was 91% and specificity was 76%, com-
pared withvirtual chromoendoscopy (NBI and FICE), which had a
sensitivity of 77% and a specificity of 71% [27].
This same group evaluated the learning curve for pCLE for colo-
rectal polyps and found that new users rapidly acquired the abil-
ity to interpret pCLE images with accuracy similar tothatof high-
ly experienced experts. New users were able to interpret images
with an accuracy of 93% after reading at least 35 cases. This study
did not assess the accuracy of new users during live video endos-
copies, which may require more experience [28].
Further prospective studies and data are eagerly awaited that ex-
amine the cost-effectiveness of CLE for colorectal polyps with
both the integrated as well as the probe-based system. Data on
the assessment of degree of dysplasia, inter-observer variability,
and learning curve are also anticipated. At the same time, other
applications for the use of the CLE system (e.g. early detection of
adenomatous tissue at a scar at the resection site of a polyp),
should be explored.
● " Fig.4 shows the criteria for pCLE classification of colorectal
polyps.
Fig.3 Bile duct. a Normal appearing bile duct with fine, reticular gray
pattern (thin black arrow). b Biliary cancer. Note dark, irregular structures
(thin black arrow) interspersed with bright areas of tortuous dilated blood
vessel (thick white arrow).
Wallace M et al. Miami classification for pCLE… Endoscopy 2011; 43: 882–891
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.Fig.4 Colon. a Graphic showing colonic mucosa
progressing from normal crypts (left side) to dys-
plastic crypts and villiform structures (right side).
b Panels showing probe-based confocal laser endo-
microscopy images and hematoxylin and eosin
images of colonic disease.
Normal colon
Hyperplastic polyp
– Round crypt structures
– Dark goblet cells 
 (arrow)
– Regular, narrow vessels 
 surrounding  crypts 
 (block  arrow)
– Crypts with slit or 
  stellate openings (pits) 
– Bright non-thickened, 
 uniform  epithelium
– Dark „goblet“ cells 
 (thin  arrow)
– Small vessels (block 
 arrow)
Adenoma
– Irregular or villiform 
  structures (note even 
 „tubular“  adenoma 
  may have villiform 
  structure on pCLE)
– Dark, irregularly 
 thickened  epithelium
– Decreased goblet cells
Adenocarcinoma
– Disorganized villiform 
  or lack of structure
– Dark, irregularly 
 thickened  epithelium 
 (thin  arrow)
– Dilated vessels 
  (block arrow on H&E)
Colitis
b
– Crypt fusion and 
 distortion  (arrow)
– Bright epithelium 
– Dilated, prominent 
 branching  vessels 
 (block  arrow)
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.Ulcerative colitis
!
As patients with ulcerative colitis have an increased riskof devel-
oping dysplasia, guidelines recommend colonoscopic surveil-
lance including targeted biopsies of suspicious lesions and multi-
ple (40) random biopsies. However, the yield for dysplasia on
random biopsy is very low, and standard endoscopic imaging
cannot identify most neoplastic lesions. Several randomized
studies have shown that targeting biopsies with chromoendosco-
py significantly increases dysplasia detection rates in patients
with longstanding ulcerative colitis [29,30]. In one randomized
study, ETMI also increased dysplasia detection rates but NBI did
not [31,32].
Using initial chromoscopy followed by directed eCLE combines
the strengths of both techniques in ulcerative colitis. While pan-
chromoscopy facilitates the detection of flat lesions in ulcerative
colitis, subsequent targeted confocal endomicroscopy can be
used to differentiate between neoplastic and non-neoplastic tis-
sue, thus obviating the need for targeted biopsies of lesions that
appeared non-neoplastic. This can also be used to possibly differ-
entiate random biopsies in chromo-negative areas. By using this
diagnostic approach in a randomized study in 161 patients, Kies-
slich et al. detected almost five times more dysplastic lesions
than conventional colonoscopy with random biopsies [33].
Using the integrated CLE system, Hurlstone et al. demonstrated a
high overall accuracy of 97% for in vivo differentiation of adeno-
ma-like mass (ALM) and dysplasia-associated lesion or mass
(DALM) in patients with chronic ulcerative colitis [34]. Case re-
ports using the pCLE system suggest it may also be used to iden-
tify DALM lesions [35].This technique could provide gastroenter-
ologists with important information for selecting patients who
are suitable for immediate endoscopic resection vs. referral for
pan-proctocolectomy. Recent studies also suggest that CLE may
be a valuable tool for the grading of colitis and detection of mi-
croscopiccolitis in regions of the colonwithout visible inflamma-
tion [36].
All of these studies have been performed with the integrated CLE
system. Studies with the probe-based CLE system are currently
underway. Further data from non-tertiary referral centers and
from investigation of the learning curve and inter-observer
agreement in patients with chronic ulcerative colitis are neces-
sary before implementation of chromoscopy-guided CLE can be
recommended in daily practice.
● " Fig.4 shows the criteria for pCLE classification of colitis and
associated dysplasia.
Normal stomach
Gastritis
– Round regular crypts 
 (“pits“,  arrow)
– „Cobblestone“ 
  appearence of normal 
  glands (block arrow)
– Increased fluorescence 
  (brightness) in stroma 
 (arrow)
– Cellular infiltrate 
 between  pits 
 (block  arrow)
Gastric dysplasia
– Irregular crypt lumen
– Dark, irregular,
 thickened  epithelium
Gastric adenocarcinoma
– Completely 
 disorganized  epithelium
– Fluorescein leakage 
 (arrow)
– Dark irregular 
 epithelium
Fig.5 Stomach. Panels showing probe-based confocal laser endomicros-
copy images (normal, dysplasia, adenocarcinoma) and hematoxylin and
eosin images of gastric disease. (Gastritis images kindly provided by Alex-
ander Meining).
Normal duodenum
Duodenal adenoma
– Villiform architecture
– Bright, uniform 
 epithelium
– Villiform architecture
– Dark, irregular 
 epithelium  (arrow)
Duodenum celiac disease
– Blunting or loss of villi 
 (arrow)
– Expansion of lamina 
  propia with chronic 
 inflammatory  cells 
  (arrow head, H&E)
Fig.6 Duodenum. Probe-based confocal laser endomicroscopy (pCLE)
images and hematoxylin and eosin of normal and diseased duodenum. The
top two panels show the high definition (UHD, Cellvizio, Mauna Kea Tech-
nologies, Paris) probe of normal and adenomatous duodenum. The field of
view was expanded using “mosaicing” software, which integrates multiple
side-by-side frames into a single panoramic view. The bottom pCLE image
(celiac disease) was obtained using the Z probe (Cellvizio, Mauna Kea),
which provides a lower-resolution but wider field of view.
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.Gastric diseases
!
To date there are limited data exploring application of confocal
imaging to the stomach. There is a potential role for CLE in the
discrimination of indeterminate gastric lesions in countries
where gastric cancer is more common and screening endosco-
pies are performed. In two studies from Japan, CLE demonstrated
typical features ofdysplasia such as enlarged and increased num-
bers of nuclei[37]. CLE had an accuracyof 94–96% fordiagnosis of
malignancy among 27 patients with early gastric cancer, when
compared directly with histological biopsies [38]. Other potential
but unexplored applications include distinction between adeno-
matous and fundic gland polyps. ● " Fig.5 shows typical pCLE
images of normal gastric mucosa, inflammation, and dysplasia.
Duodenal diseases
!
As with the stomach, there are limited data on duodenal applica-
tions. Given the frequency of biopsies performed to detect celiac
disease in patients with signs or symptomsof malabsorption, this
would be a valuable role for CLE, especially given the relatively
low yield of endoscopic biopsy. Two small case reports have sug-
gested that confocal endomicroscopy can detect villous atrophy
and increased intra-epithelial cellularity (presumed to be lym-
phocytes) [39,40]. In a recent study of 17 patients with celiac dis-
ease and 14 control individuals, CLE detected typical celiac
changes of villous atrophy and crypt hypertrophy. The accuracy
of CLE was excellent, with sensitivity of 94% and specificity of
92% [41].
Detection of duodenal adenomas is also a potentially valuable
role for CLE. The risk of ampullary and non-ampullary duodenal
cancer is substantially elevated in familial adenomatous polypo-
sis, leading to recommendations for routine duodenal surveil-
lance and ampullary biopsy [42]. Adownside of biopsyof the am-
pulla is the riskof inducing acutepancreatitis [43], suchthat non-
biopsy methods would be preferable. Preliminary data from Sha-
hid et al. at the Mayo Clinic (Florida, USA) suggest that pCLE may
be highly accurate for the detection of both ampullary and non-
ampullary adenomas, although more data are needed [44]. The
features of dysplasia are typical of those in other gastrointestinal
sites including dark, irregular epithelium (● " Fig.6).
Research priorities
!
To determine the value of these potential roles and explore new
ones, critical research is needed, including in the following areas.
▶ Determine precise estimates of accuracy compared with cur-
rent standard endoscopic methods in colon polyps, Barrett’s
esophagus, ulcerative colitis, biliary cancer, and gastric dys-
plasia.
▶ Determine the reliability of pCLE in a community setting.
▶ Assess the ability to guide immediate endoscopic therapy in
Barretts-associated dysplasia, colorectal endoscopic mucosal
resection, and polypectomy.
▶ Determine preliminary accuracy and reliability in bile duct
cancer.
▶ Assess the cost-effectiveness of pCLE compared with standard
competing technologies including biopsy.
▶ Develop improved methods for image stabilization.
▶ Develop improved methods for image interpretation systems
including computer-aided diagnosis.
▶ Assess the feasibility and accuracy of intratumoral and intra-
cystic CLE via needles (nCLE).
Summary and future directions
!
pCLE has the potential to directly guide endoscopic therapy of
dysplasia and significantly reduce the number of non-targeted
(random) biopsies. Application of this technology has the further
advantage of visualizing a dynamic processon a microscopiclevel
for monitoring and determination of blood flow in various condi-
tions. Further miniaturization of the probe will imply new indi-
cations, such as placing the miniprobe through an FNA needle
for EUS-guided examinations of solid or cystic tumors and for in-
terventions. In addition, integrating new biological fluorophores
such as fluorescein-bound peptides will potentially enable the
precise detection of dysplasia in vivo and guide subsequent inter-
vention during the same procedure.
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